Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL > Treatment > USA. T. Bortezomib
USA. T. Bortezomib's subsections
(*) USA Approval Date: Since 2006
(**) EU Approval Date: 2015. 02.06
(**) USA Approval Date: 2014. 10.10
>Previously UnTreated (**)
>R/R Treat. (*)
Company
Company CoDevelopment (EU)
Mechanism: Proteasome Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2006. 03.14.
TradeMark
TradeMark Web-Site
USA. T. Bortezomib's products
This section has no products